Regulating patent offices: countering pharmaceutical hegemony
The grant of a patent is not a reward. Rather it is an opportunity for the patent owner to pursue profits using the patent monopoly to exclude competition. Profit-maximising patent owners focus their monopoly powers on markets in which profits are the greatest. In the case of patents over medical products this leads to well known problems of access to medicines for poor people. The costs and abuses of the patent system in the pharmaceutical sector have been persistent and known for a long...[Show more]
|Collections||ANU Research Publications|
|Drahos_Regulating2008.pdf||225.78 kB||Adobe PDF|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.